While the funding announcement itself would typically be positive, the prominent retraction notice at the beginning of the article severely undermines credibility. The instruction to disregard the news release suggests potential issues with the announcement, making the overall sentiment negative despite the $8M funding claim.
Pasithea Therapeutics news
$0.4900+2.08%
Close Sep 29, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About Pasithea Therapeutics
No recent articles focused on Pasithea Therapeutics.
Also mentions KTTA
Articles that tag KTTA but are mainly about other companies.
GlobeNewswire Inc.Jul 2, 10:41 AM ET▼ Negative
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology